Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PTLA

Portola Pharmaceuticals

$47.73

-0.91 (-1.87%)

, REGN

Regeneron

$384.80

-8.82 (-2.24%)

04:55
11/15/17
11/15
04:55
11/15/17
04:55
Conference/Events
American Heart Association to hold annual meeting »

AHA Annual Meeting 2017…

PTLA

Portola Pharmaceuticals

$47.73

-0.91 (-1.87%)

REGN

Regeneron

$384.80

-8.82 (-2.24%)

AMGN

Amgen

$170.13

-1.37 (-0.80%)

CYTK

Cytokinetics

$11.25

-0.35 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 02

    Dec

  • 09

    Dec

  • 02

    Feb

  • 03

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

Over a week ago
PTLA

Portola Pharmaceuticals

$48.64

-0.31 (-0.63%)

, REGN

Regeneron

$393.62

-10.92 (-2.70%)

07:11
11/14/17
11/14
07:11
11/14/17
07:11
Conference/Events
American Heart Association to hold annual meeting »

AHA Annual Meeting 2017…

PTLA

Portola Pharmaceuticals

$48.64

-0.31 (-0.63%)

REGN

Regeneron

$393.62

-10.92 (-2.70%)

AMGN

Amgen

$171.50

-0.85 (-0.49%)

CYTK

Cytokinetics

$11.60

-0.95 (-7.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 02

    Dec

  • 09

    Dec

  • 02

    Feb

  • 03

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

PTLA

Portola Pharmaceuticals

$49.17

-2.4 (-4.65%)

16:10
11/06/17
11/06
16:10
11/06/17
16:10
Earnings
Portola Pharmaceuticals reports Q3 EPS ($1.41), consensus ($1.46) »

Reports Q3 revenue $3.8M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 06

    Nov

  • 02

    Feb

PTLA

Portola Pharmaceuticals

$51.57

1.88 (3.78%)

08:12
11/06/17
11/06
08:12
11/06/17
08:12
Hot Stocks
Portola Pharmaceuticals appoints John Lawrence, M.D. as chief medical officer »

Portola Pharmaceuticals …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 06

    Nov

  • 02

    Feb

Over a month ago
PTLA

Portola Pharmaceuticals

$54.38

-0.37 (-0.68%)

09:55
10/12/17
10/12
09:55
10/12/17
09:55
Conference/Events
William Blair biotech analyst holds an analyst/industry conference call »

Biotech Analyst Phipps,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 06

    Nov

  • 02

    Feb

PTLA

Portola Pharmaceuticals

$54.38

-0.37 (-0.68%)

04:55
10/12/17
10/12
04:55
10/12/17
04:55
Conference/Events
William Blair biotech analyst holds an analyst/industry conference call »

Biotech Analyst Phipps,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 06

    Nov

  • 02

    Feb

PTLA

Portola Pharmaceuticals

$54.17

-0.22 (-0.40%)

10:52
10/04/17
10/04
10:52
10/04/17
10:52
Conference/Events
William Blair biotech analyst holds an analyst/industry conference call »

Biotech Analyst Phipps,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

PTLA

Portola Pharmaceuticals

$52.09

-4.48 (-7.92%)

09:03
09/20/17
09/20
09:03
09/20/17
09:03
Recommendations
Portola Pharmaceuticals analyst commentary at Credit Suisse »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

13:31
09/19/17
09/19
13:31
09/19/17
13:31
Recommendations
Portola Pharmaceuticals analyst commentary at Citi »

Portola selloff on draft…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

12:58
09/19/17
09/19
12:58
09/19/17
12:58
Recommendations
Portola Pharmaceuticals analyst commentary at Oppenheimer »

Portola selloff today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.